Molecular pathways of cyclic nucleotide‐induced inhibition of arterial smooth muscle cell proliferation
暂无分享,去创建一个
[1] K. Fujishige,et al. Isolation and Characterization of Two Novel Phosphodiesterase PDE11A Variants Showing Unique Structure and Tissue-specific Expression* , 2000, The Journal of Biological Chemistry.
[2] D. Tilley,et al. Expression of Phosphodiesterase 4D (PDE4D) Is Regulated by Both the Cyclic AMP-dependent Protein Kinase and Mitogen-activated Protein Kinase Signaling Pathways , 2000, The Journal of Biological Chemistry.
[3] D. Maurice,et al. Dual expression and differential regulation of phosphodiesterase 3A and phosphodiesterase 3B in human vascular smooth muscle: implications for phosphodiesterase 3 inhibition in human cardiovascular tissues. , 2000, Molecular pharmacology.
[4] E. Lam,et al. Inhibition of the Phosphoinositide 3-Kinase Pathway Induces a Senescence-like Arrest Mediated by p27Kip1 * , 2000, The Journal of Biological Chemistry.
[5] A. Wittinghofer,et al. Mechanism of Regulation of the Epac Family of cAMP-dependent RapGEFs* , 2000, The Journal of Biological Chemistry.
[6] T. Clemens,et al. Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells. , 2000, American journal of physiology. Endocrinology and metabolism.
[7] S. Jin,et al. Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Oz,et al. cAMP pulse during preservation inhibits the late development of cardiac isograft and allograft vasculopathy. , 2000, Circulation research.
[9] M. Moran,et al. The guanine nucleotide exchange factor CNrasGEF activates Ras in response to cAMP and cGMP , 2000, Current Biology.
[10] E. Nabel,et al. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. , 2000, Circulation.
[11] M. Gu,et al. Nitric Oxide Increases p21Waf1/Cip1 Expression by a cGMP-dependent Pathway That Includes Activation of Extracellular Signal-regulated Kinase and p70 S6k * , 2000, The Journal of Biological Chemistry.
[12] J. Baldassare,et al. Phosphatidylinositol 3-Kinase Activity Regulates α-Thrombin-stimulated G1 Progression by Its Effect on Cyclin D1 Expression and Cyclin-dependent Kinase 4 Activity* , 2000, The Journal of Biological Chemistry.
[13] J. Beavo,et al. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. , 2000, Current opinion in cell biology.
[14] A. Toker. Protein kinases as mediators of phosphoinositide 3-kinase signaling. , 2000, Molecular pharmacology.
[15] J. Beavo,et al. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[16] K. Omori,et al. Binding and Phosphorylation of a Novel Male Germ Cell-specific cGMP-dependent Protein Kinase-anchoring Protein by cGMP-dependent Protein Kinase Iα* , 2000, The Journal of Biological Chemistry.
[17] MiaofenGu,et al. Nitric Oxide–Induced Increase in p21Sdi1/Cip1/Waf1 Expression During the Cell Cycle in Aortic Adventitial Fibroblasts , 2000 .
[18] T. Clemens,et al. Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells. , 2000, American journal of physiology. Endocrinology and metabolism.
[19] M. Gu,et al. Nitric oxide-induced increase in p21(Sdi1/Cip1/Waf1) expression during the cell cycle in aortic adventitial fibroblasts. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[20] M. Crouch,et al. Nitric oxide donors selectively potentiate thrombin-stimulated p70(S6k) activity and morphological changes in Swiss 3T3 cells. , 1999, Biochemical and biophysical research communications.
[21] S. Christensen,et al. Suppression of human inflammatory cell function by subtype‐selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B , 1999, British journal of pharmacology.
[22] S. Fukumoto,et al. Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation. , 1999, Circulation research.
[23] T. Lincoln,et al. Activation of Mitogen-activated Protein Kinase Pathways by Cyclic GMP and Cyclic GMP-dependent Protein Kinase in Contractile Vascular Smooth Muscle Cells* , 1999, The Journal of Biological Chemistry.
[24] G. Thomas,et al. Ribosomal S6 kinase signaling and the control of translation. , 1999, Experimental cell research.
[25] M. Waterfield,et al. Signaling by distinct classes of phosphoinositide 3-kinases. , 1999, Experimental cell research.
[26] T. Sasaguri,et al. Tumor Suppressor p53 But Not cGMP Mediates NO-Induced Expression of p21Waf1/Cip1/Sdi1 in Vascular Smooth Muscle Cells , 1999 .
[27] I. Zachary,et al. Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells. , 1999, The Biochemical journal.
[28] K. Bornfeldt,et al. Cyclic Nucleotide Phosphodiesterases and Human Arterial Smooth Muscle Cell Proliferation , 1999, Thrombosis and Haemostasis.
[29] K. Sadhu,et al. Differential Expression of the Cyclic GMP-stimulated Phosphodiesterase PDE2A in Human Venous and Capillary Endothelial Cells , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[30] E. Krebs,et al. Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. , 1999, Cellular signalling.
[31] K. Fujishige,et al. Cloning and Characterization of a Novel Human Phosphodiesterase That Hydrolyzes Both cAMP and cGMP (PDE10A)* , 1999, The Journal of Biological Chemistry.
[32] P. B. Snyder,et al. Isolation and characterization of PDE10A, a novel human 3', 5'-cyclic nucleotide phosphodiesterase. , 1999, Gene.
[33] James M. Roberts,et al. CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.
[34] J. Beavo,et al. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[35] Andrius Kazlauskas,et al. PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1 , 1999, Current Biology.
[36] M. Marletta,et al. Guanylate cyclase and the .NO/cGMP signaling pathway. , 1999, Biochimica et biophysica acta.
[37] P. Ruth,et al. Cyclic GMP-dependent protein kinases: understanding in vivo functions by gene targeting. , 1999, Pharmacology & therapeutics.
[38] A. Hassid,et al. Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: relationship to microfilament dissociation and altered cell morphology. , 1999, Circulation research.
[39] Y. Takuwa,et al. Cyclin D1 Expression Mediated by Phosphatidylinositol 3-Kinase through mTOR-p70S6K-Independent Signaling in Growth Factor-Stimulated NIH 3T3 Fibroblasts , 1999, Molecular and Cellular Biology.
[40] R. Busse,et al. Growth‐inhibitory effect of cyclic GMP‐ and cyclic AMP‐dependent vasodilators on rat vascular smooth muscle cells: effect on cell cycle and cyclin expression , 1999, British journal of pharmacology.
[41] J. Beavo,et al. Isolation and characterization of a dual-substrate phosphodiesterase gene family : PDE 10 A , 1999 .
[42] J. Lawrence,et al. Attenuation of Mammalian Target of Rapamycin Activity by Increased cAMP in 3T3-L1 Adipocytes* , 1998, The Journal of Biological Chemistry.
[43] A M Graybiel,et al. A family of cAMP-binding proteins that directly activate Rap1. , 1998, Science.
[44] S. Antonarakis,et al. Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene (PDE9A) that maps to 21q22.3: alternative splicing of mRNA transcripts, genomic structure and sequence , 1998, Human Genetics.
[45] A. Wittinghofer,et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP , 1998, Nature.
[46] J. Hurley. The adenylyl and guanylyl cyclase superfamily. , 1998, Current opinion in structural biology.
[47] S. Lohmann,et al. Cyclic-GMP-Dependent Protein Kinase Inhibits the Ras/Mitogen-Activated Protein Kinase Pathway , 1998, Molecular and Cellular Biology.
[48] K. Ferguson,et al. Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3',5'-cyclic nucleotide phosphodiesterase. , 1998, Gene.
[49] J. Beavo,et al. Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[50] K. Fujishige,et al. Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene. , 1998, European journal of biochemistry.
[51] R. Tuder,et al. Role of adenylyl cyclase in proliferation of neonatal pulmonary artery smooth muscle cells. , 1998, Chest.
[52] James F. Smith,et al. Isolation and Characterization of PDE9A, a Novel Human cGMP-specific Phosphodiesterase* , 1998, The Journal of Biological Chemistry.
[53] J. Beavo,et al. Identification and Characterization of a Novel Family of Cyclic Nucleotide Phosphodiesterases* , 1998, The Journal of Biological Chemistry.
[54] J. Cheng,et al. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase. , 1998, Biochemical and biophysical research communications.
[55] V. Coghlan,et al. Identification of cGMP-dependent protein kinase anchoring proteins (GKAPs). , 1998, Biochemical and biophysical research communications.
[56] D. Collen,et al. Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. , 1998, Circulation.
[57] S. Mittnacht,et al. Control of pRB phosphorylation. , 1998, Current opinion in genetics & development.
[58] J. Corbin,et al. ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. , 1998, American journal of physiology. Heart and circulatory physiology.
[59] M. Houslay,et al. Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene. , 1997, The Biochemical journal.
[60] E. Krebs,et al. Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype. , 1997, The Journal of clinical investigation.
[61] A. Takeshita,et al. Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/paracrine loop. , 1997, Circulation.
[62] K. Jarnagin,et al. Multiple splice variants of phosphodiesterase PDE4C cloned from human lung and testis. , 1997, Biochimica et biophysica acta.
[63] U. Walter,et al. Distinct and specific functions of cGMP-dependent protein kinases. , 1997, Trends in biochemical sciences.
[64] P. Vadiveloo,et al. G1 phase arrest of human smooth muscle cells by heparin, IL-4 and cAMP is linked to repression of cyclin D1 and cdk2. , 1997, Atherosclerosis.
[65] E. Duzic,et al. Adenylyl cyclase isoforms and vasopressin enhancement of agonist-stimulated cAMP in vascular smooth muscle cells. , 1997, The American journal of physiology.
[66] G. Condorelli,et al. Activation of cAMP–PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury , 1997, Nature Medicine.
[67] K. Ferguson,et al. Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase. , 1997, Gene.
[68] J. Scott,et al. Protein Kinase A Anchoring* , 1997, The Journal of Biological Chemistry.
[69] H. Nojima,et al. Induction of the Cyclin-dependent Kinase Inhibitor p21Sdi1/Cip1/Waf1 by Nitric Oxide-generating Vasodilator in Vascular Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.
[70] L. Hung,et al. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. , 1997, Circulation.
[71] A. Hassid,et al. NO increases protein tyrosine phosphatase activity in smooth muscle cells: relationship to antimitogenesis. , 1997, The American journal of physiology.
[72] Y. Ishikawa,et al. The adenylyl cyclases as integrators of transmembrane signal transduction. , 1997, Circulation research.
[73] T. Honjo,et al. Inhibition of Carnitine Palmitoyltransferase I Augments Sphingolipid Synthesis and Palmitate-induced Apoptosis* , 1997, The Journal of Biological Chemistry.
[74] M. Sandrin,et al. Switching Amino-terminal Cytoplasmic Domains of α(1,2)Fucosyltransferase and α(1,3)Galactosyltransferase Alters the Expression of H Substance and Galα(1,3)Gal* , 1996, The Journal of Biological Chemistry.
[75] R. Buscà,et al. Inhibition of the Phosphatidylinositol 3-Kinase/p70S6-Kinase Pathway Induces B16 Melanoma Cell Differentiation* , 1996, The Journal of Biological Chemistry.
[76] James M. Roberts,et al. Fibrillar Collagen Inhibits Arterial Smooth Muscle Proliferation through Regulation of Cdk2 Inhibitors , 1996, Cell.
[77] J. Beavo,et al. Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[78] F. Murad. Signal Transduction Using Nitric Oxide and Cyclic Guanosine Monophosphate , 1996 .
[79] F. Murad. The 1996 Albert Lasker Medical Research Awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate. , 1996, JAMA.
[80] S. Fukumoto,et al. The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2. , 1996, Circulation research.
[81] A. Peacock,et al. A regulatory role for cAMP in phosphatidylinositol 3-kinase/p70 ribosomal S6 kinase-mediated DNA synthesis in platelet-derived-growth-factor-stimulated bovine airway smooth-muscle cells. , 1996, The Biochemical journal.
[82] J. Pouysségur,et al. cAMP-mediated Growth Inhibition in Fibroblasts Is Not Mediated via Mitogen-activated Protein (MAP) Kinase (ERK) Inhibition , 1996, The Journal of Biological Chemistry.
[83] G. Muirhead,et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. , 1996, International journal of impotence research.
[84] J. Catravas,et al. cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue , 1996, Journal of cellular physiology.
[85] L. Graves,et al. Insulin, growth factors, and cAMP Antagonism in the signal transduction pathways , 1996, Trends in Endocrinology & Metabolism.
[86] A. Hassid,et al. Atrial and C-type natriuretic peptides amplify growth factor activity in primary aortic smooth muscle cells. , 1996, Cardiovascular research.
[87] E. Degerman,et al. Type III cyclic nucleotide phosphodiesterases and insulin action. , 1996, Current topics in cellular regulation.
[88] J. Pouysségur,et al. TGF-beta 1 and cAMP attenuate cyclin A gene transcription via a cAMP responsive element through independent pathways. , 1995, Oncogene.
[89] J. Beavo,et al. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. , 1995, Physiological reviews.
[90] T. Hunter,et al. Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. , 1995, Molecular biology of the cell.
[91] E. Krebs,et al. cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[92] M. Conti,et al. Recent progress in understanding the hormonal regulation of phosphodiesterases. , 1995, Endocrine reviews.
[93] J. Blenis,et al. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP , 1995, Molecular and cellular biology.
[94] S. M. Van Patten,et al. Multiple pathway signal tran sduction by the cAMP‐dependent protein kinase , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[95] M. Pierre,et al. Inhibition of G1 cyclin expression and G1 cyclin-dependent protein kinases by cAMP in an astrocytic cell line. , 1994, Biochemical and biophysical research communications.
[96] J. Massagué,et al. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27 Kip1 ) of cyclin-dependent kinase 4 activation , 1994, Cell.
[97] E. Arnold,et al. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. , 1994, The American journal of physiology.
[98] W. Kolch,et al. Mechanism of inhibition of Raf-1 by protein kinase A , 1994, Molecular and cellular biology.
[99] T. Bourcier,et al. Nitric oxide selectively amplifies FGF-2-induced mitogenesis in primary rat aortic smooth muscle cells. , 1994, The American journal of physiology.
[100] B. Schaffhausen,et al. The hunt for Ras targets , 1994, Nature.
[101] X. F. Zhang,et al. Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues , 1994, Molecular and cellular biology.
[102] D. Garbers,et al. Guanylyl cyclase receptors. , 1994, The Journal of biological chemistry.
[103] B. Schaffhausen,et al. Signal transduction. The hunt for Ras targets. , 1994, Nature.
[104] S. Cook,et al. Inhibition by cAMP of Ras-dependent activation of Raf. , 1993, Science.
[105] P. Dent,et al. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate. , 1993, Science.
[106] E. Krebs,et al. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[107] J. Lawrence,et al. Increasing cAMP attenuates activation of mitogen-activated protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[108] Charles J. Sherr,et al. Mammalian G1 cyclins , 1993, Cell.
[109] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[110] F. C. Lucibello,et al. Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. , 1993, Journal of cell science.
[111] M. Hallett,et al. Inhibition of proliferation, but not of Ca2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells. , 1992, The Biochemical journal.
[112] J. Nevins,et al. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.
[113] N. Minamino,et al. C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells. , 1991, Biochemical and biophysical research communications.
[114] J. Scott. Cyclic nucleotide-dependent protein kinases. , 1991, Pharmacology & therapeutics.
[115] T. Nakaki,et al. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. , 1990, European journal of pharmacology.
[116] A. Newby,et al. Serum-induced proliferation of rabbit aortic smooth muscle cells from the contractile state is inhibited by 8-Br-cAMP but not 8-Br-cGMP. , 1990, Atherosclerosis.
[117] Susan S. Taylor,et al. cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. , 1990, Annual review of biochemistry.
[118] K. Kariya,et al. Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. , 1989, Atherosclerosis.
[119] A. Richards,et al. Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor. , 1989, Biochemical and biophysical research communications.
[120] A. Hassid,et al. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.
[121] T. Lincoln,et al. Regulation of intracellular Ca2+ levels in cultured vascular smooth muscle cells. Reduction of Ca2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. , 1989, The Journal of biological chemistry.